Arthrx Fracture Plates

K213837 · Arthrex, Inc. · HRS · May 2, 2022 · Orthopedic

Device Facts

• Record ID: K213837
• Device Name: Arthrx Fracture Plates
• Applicant: Arthrex, Inc.
• Product Code: HRS · Orthopedic
• Decision Date: May 2, 2022
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Arthrex Fracture Plates are intended to be used for internal bone fractures, fusions, osteotomies and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibula. The Arthrex Low Profile Screws (2.5mm and larger, solid) are intended to be used as stand-alone bone screws, or in a plate-screw system for internal bone fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humers, radius, ulna, tibia, calcaneous, femur, and fibula. When used with a plate, the screws may be used with the Arthrex Low Profile, Small Fragment Plates, Distal Extremity Plates, Humeral Fracture Plates, and Osteotomy Plates. The Arthrex Low Profile Screws (3.5mm and larger, cannulated) are intended to be used as stand-alone bone screws for internal bone fixation for bone fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibia, calcaneous, femur and fibula.

Device Story

System consists of anatomically contoured metallic plates and screws for internal fixation of distal tibia fractures and other orthopedic sites; plates provide locking screw fixation. Device used in clinical/surgical settings by orthopedic surgeons. Inputs are patient anatomy; device transforms these via mechanical fixation to stabilize bone segments. Output is rigid internal fixation; aids bone healing/fusion. Benefits include anatomical restoration and stabilization of fractures. Sold sterile (Gamma) or non-sterile; single-use.

Clinical Evidence

Bench testing only. Mechanical performance validated via Pull-out (ASTM F543-17), Failure Torque, Insertion Torque (ASTM F543-17), and 4-Point Bend (ASTM F382-17). MR safety evaluated per ASTM F2052, F2119, F2182, and F2213. Biocompatibility/pyrogenicity confirmed via Bacterial Endotoxins Test (BET) per ANSI/AAMI ST72, USP <161>, USP <85>, and EP 2.6.14.

Technological Characteristics

Plates and screws manufactured from Titanium Alloy (Ti-6AL-4V, ASTM F136). Plates anatomically contoured for talus/distal tibia; locking screw fixation. Screws include solid (non-locking/locking) and cannulated (non-locking) variants. Sterilization via Gamma radiation. MR Conditional. No software or electronic components.

Indications for Use

Indicated for patients requiring internal bone fixation for fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibia, calcaneus, femur, and fibula.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• Arthrex Fracture Plates (K123241)

Reference Devices

• Arthrex Fracture Plates (K151732)
• Arthrex Pilon Fusion System (K203294)

Submission Summary (Full Text)

{0}------------------------------------------------

May 2, 2022

Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a seal with an abstract design. To the right of the seal, there is a blue square with the letters "FDA" in white. Next to the blue square, the words "U.S. FOOD & DRUG" are written in blue, with the word "ADMINISTRATION" written in a smaller font size below.

Arthrex Inc. Stacy Valdez Senior Regulatory Affairs Specialist 1370 Creekside Boulevard Naples, Florida 34108-1945

Re: K213837

Trade/Device Name: Arthrex Ankle Fracture System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: December 7, 2021 Received: December 9, 2021

Dear Stacy Valdez:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known)

## K213837

Device Name Arthrex Fracture Plates

#### Indications for Use (Describe)

The Arthrex Fracture Plates are intended to be used for internal bone fractures, fusions, osteotomies and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibula.

Type of Use (Select one or both, as applicable)

| <input type="checkbox"/> Research Use (Part 21 CFR 601 Subpart D) | <input type="checkbox"/> Compassionate Use (21 CFR 601 Subpart E) |
|-------------------------------------------------------------------|-------------------------------------------------------------------|
|-------------------------------------------------------------------|-------------------------------------------------------------------|

× | Prescription Use (Part 21 CFR 801 Subpart D)

__ Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## Indications for Use

510(k) Number (if known)

#### K213837

Device Name Arthrex Low Profile Screws

#### Indications for Use (Describe)

The Arthrex Low Profile Screws (2.5mm and larger, solid) are intended to be used as stand-alone bone screws, or in a plate-screw system for internal bone fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humers, radius, ulna, tibia, calcaneous, femur, and fibula. When used with a plate, the screws may be used with the Arthrex Low Profile, Small Fragment Plates, Distal Extremity Plates, Humeral Fracture Plates, and Osteotomy Plates.

The Arthrex Low Profile Screws (3.5mm and larger, cannulated) are intended to be used as stand-alone bone screws for internal bone fixation for bone fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibia, calcaneous, femur and fibula.

| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|

× | Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

# 510(k) Summary

| Date Prepared | February 04, 2022 |
|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter | Arthrex Inc. |
| | 1370 Creekside Boulevard |
| | Naples, FL 34108-1945 |
| Contact Person | Stacy Valdez |
| | Senior Regulatory Affairs Specialist |
| | 1-239-643-5553, ext. 72010 |
| | [e-mail] |
| Name of Device | Arthrex Ankle Fracture System |
| Common Name | Plate, fixation, bone |
| Product Code | HRS (Primary), HWC |
| Classification Name | 21 CFR 888.3030: Single/multiple component metallic bone fixation appliances |
| | and accessories (Primary) |
| | 21 CFR 888.3040: Smooth or threaded metallic bone fastener |
| Regulatory Class | II |
| Primary Predicate | K123241: Arthrex Fracture Plates |
| Reference Devices | K151732: Arthrex Fracture Plates |
| | K203294: Arthrex Pilon Fusion System |
| Purpose of | This Traditional 510(k) premarket notification is submitted to obtain clearance for |
| Submission | the Arthrex Ankle Fracture System. |
| Device Description | The proposed Arthrex Ankle Fracture System consists of a series of plates and |
| | screws of varying lengths and orientations for versatile treatment of distal tibia |
| | fractures. The Ankle Fracture System Plates consist of posterior and vertical |
| | plates that are anatomically contoured to provide fixation in the talus and may be |
| | available in left and right configurations. Each plate provides locking screw |
| | fixation. The proposed Arthrex Low Profile Screws are a family of fully threaded, |
| | solid, non-locking or locking screws; and partially threaded, cannulated and non- |
| | locking screws. The proposed plates and screws are manufactured from Titanium |
| | Alloy. The proposed plates and screws are sold sterile (Gamma) and non-sterile |
| | and are single-use. |
| | |
| Indications for Use | The Arthrex Fracture Plates are intended to be used for internal bone fixation for |
| | bone fractures, fusions, osteotomies and non-unions in the ankle, foot, hand,<br>wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibia, calcaneous, fibula. |
| | |
| | The Arthrex Low Profile Screws (2.5mm and larger, solid) are intended to be used |
| | as stand-alone bone screws, or in a plate-screw system for internal bone fixation |
| | for bone fractures, fusions, osteotomies, and non-unions in the ankle, foot, hand, |
| | wrist, clavicle, scapula, olecranon, humerus, radius, ulna, tibia, calcaneous, |
| | femur, and fibula. When used with a plate, the screws may be used with the |
| | Arthrex Low Profile, Small Fragment Plates, Fracture Plates, Distal Extremity |
| | Plates, Humeral Fracture Plates, and Osteotomy Plates. |
| | |
| | The Arthrex Low Profile Screws (3.5mm and larger, cannulated) are intended to |
| | be used as stand-alone bone screws for internal bone fixation for bone fractures, |
| | fusions, osteotomies, and non-unions in the ankle, foot, hand, wrist, clavicle, |
| | scapula, olecranon, humerus, radius, ulna, tibia, calcaneous, femur and fibula. |
| Performance Data | Arthrex conducted Pull-out (ASTM F543-17), Failure Torque, Insertion Torque |
| | (ASTM F543-17) and 4-Point Bend (ASTM F382-17) testing to demonstrate that |
| | |
| | the Arthrex Ankle Fracture System performs statistically equivalent to the<br>predicate devices cleared under K123241, K103705 and K143614. |
| | MRI force, torque, and image artifact testing were conducted in accordance with<br>FDA guidance Testing and Labeling Medical Devices for Safety in the Magnetic<br>Resonance (MR) Environment, ASTM F2052 Standard Test Method for<br>Measurement of Magnetically Induced Displacement Force on Medical Devices in<br>the Magnetic Resonance Environment, ASTM F2119 Standard Test Method for<br>Evaluation of MR Image Artifacts from Passive Implants, ASTM F2182 Standard<br>Test Method for Measurement of Measurement of Radio Frequency Induced<br>Heating Near Passive Implants During Magnetic Resonance Imaging and ASTM<br>F2213 Standard Test Method for Measurement of Magnetically Induced Torque<br>on Medical Devices in the Magnetic Resonance Environment. |
| | Arthrex Plates and Screws are tested for Bacterial Endotoxins Test (BET) utilizing<br>the Kinetic Chromogenic Method in accordance with ANSI/AAMI<br>ST72:2011/(R)2016, USP <161>, USP <85>, EP 2.6.14. The testing conducted<br>demonstrates that the sterile devices within the Arthrex Plates and Screws meet<br>pyrogen limit specifications. |
| | Assessment of physical product attributes including product, design, size, and<br>materials has determined that the Arthrex Ankle Fracture System does not<br>introduce additional risks or concerns regarding sterilization and shelf-life. |
| Technological<br>Comparison | The Arthrex Ankle Fracture System is substantially equivalent to the predicate<br>devices cleared under K123241 in which the basic design features,<br>intended use, fundamental scientific technology, materials (screws only), shelf-<br>life, and sterility are identical. |
| | The Arthrex Ankle Fracture System Plates are manufactured from Titanium Alloy<br>Ti-6AL-4V conforming to ASTM F136. The primary predicate plates cleared under<br>the Arthrex Fracture Plates, K123241 are manufactured from CP Grade 4<br>Titanium conforming to ASTM F67. The proposed Arthrex Ankle Fracture System<br>plates are offered in widths ranging from 8 mm to 10/21.1 mm. The primary<br>predicate plates cleared under the Arthrex Fracture Plates, K123241 are offered<br>in widths ranging from 9 - 13/35 mm. |
| | The sterile Arthrex Ankle Fracture System Plates are packaged in a double<br>Polyethylene/Tyvek pouch or a double Nylon/Nylon pouch. The non-sterile<br>Arthrex Ankle Fracture System plates are packaged inside a Polyethylene Bag<br>within an inner Zip-Lock Polyethylene Bag, a Double Polyethylene Bag, or a Single<br>Polyethylene Bag. The primary predicate plates cleared under Arthrex Fracture<br>Plates, K123241 are packaged in a polyethylene pouch. |
| | The sterile Arthrex Ankle Fracture System screws are packaged in a PETG Blister<br>Tray with a Tyvek Lidding or a double Polyethylene/Tyvek pouch. The non-sterile<br>Arthrex Ankle Fracture System screws are packaged inside a Polyethylene Bag<br>within an inner Zip-Lock Polyethylene Bag or a Single Polyethylene Bag. The<br>primary predicate screws cleared under Arthrex Fracture Plates, K123241 are<br>packaged in a polyethylene pouch. |
| | The Arthrex Ankle Fracture System was evaluated for MR Conditional labeling as<br>were the predicate devices cleared under K203294 and K210994. |
| | The Arthrex Ankle Fracture System is substantially equivalent to the predicate<br>devices cleared under K123241, with minor modifications with no change to<br>intended use or function. Any differences between the Arthrex Ankle Fracture<br>System and the predicate devices are considered minor and do not raise different<br>questions of safety or effectiveness. |
| Conclusion | The Arthrex Ankle Fracture System is substantially equivalent to the predicate<br>devices cleared under K123241 in which the basic design features and intended<br>use are the same. Any differences between the Arthrex Ankle Fracture System<br>and the predicate devices are considered minor and do not raise different<br>questions of safety or effectiveness. |
| | The submitted mechanical testing data demonstrates that the Pull-out, 4-Point<br>Bend strength and Failure Torque/Insertion Torque of the Arthrex Ankle Fracture<br>System is substantially equivalent to that of the predicate devices for the desired<br>indications. |
| | Based on the indications for use, technological characteristics, and the summary<br>of data submitted, Arthrex Inc. has determined that the proposed device is<br>substantially equivalent to the currently marketed predicate devices. |

{5}------------------------------------------------

{6}------------------------------------------------